Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 4801-4850 of 6046 result(s).
CYDY CytoDyn Inc
10/03/2020 2:06:57 AM
No trial results for leronlimab yet (2)
CYDY CytoDyn Inc
10/03/2020 12:30:01 AM
Bradykinin Inhibitors are the Answe (1)
CYDY CytoDyn Inc
10/03/2020 12:13:03 AM
REGN-COV2 vs. leronlimab all data R (13)
CYDY CytoDyn Inc
10/02/2020 12:38:16 PM
the fact remains that the President (7)
CYDY CytoDyn Inc
10/02/2020 10:11:52 AM
Someone posted that if Nader gets o (2)
CYDY CytoDyn Inc
10/02/2020 2:57:00 AM
Complete guess but with a non-appro (4)
CYDY CytoDyn Inc
10/01/2020 9:51:28 PM
Nader said either they enrolled the (4)
CYDY CytoDyn Inc
10/01/2020 9:40:14 PM
Any deal would be similar to what y (4)
CYDY CytoDyn Inc
10/01/2020 5:45:53 PM
The big question is -- if Vyera pri (1)
CYDY CytoDyn Inc
10/01/2020 4:41:47 PM
The initial Montefiore patients wer (3)
CYDY CytoDyn Inc
10/01/2020 3:02:46 AM
Why so many deaths? We know early o (10)
CYDY CytoDyn Inc
09/30/2020 6:31:26 PM
This is reflected in his actions in
CYDY CytoDyn Inc
09/30/2020 6:18:45 PM
Dexamethasone had the best survival (6)
CYDY CytoDyn Inc
09/30/2020 3:07:25 PM
With the HIV BLA they want all the (8)
CYDY CytoDyn Inc
09/30/2020 2:39:37 PM
From an earlier post of mine. I thi (11)
CYDY CytoDyn Inc
09/30/2020 2:22:16 PM
Receptor occupancy was for use in t (14)
CYDY CytoDyn Inc
09/29/2020 7:12:08 PM
The question I sent off for the sha (12)
CYDY CytoDyn Inc
09/29/2020 4:34:23 PM
I would hope the DSMC would look pa (3)
CYDY CytoDyn Inc
09/29/2020 4:02:15 PM
I have been banging the drum for Cy (10)
CYDY CytoDyn Inc
09/29/2020 3:45:10 PM
No drug regulatory agency does an a (5)
CYDY CytoDyn Inc
09/29/2020 7:17:15 AM
ohm: as for the Brits, are you awar (2)
CYDY CytoDyn Inc
09/28/2020 6:47:03 PM
This just goes to show the bias tha (12)
CYDY CytoDyn Inc
09/28/2020 5:42:55 PM
I can understand why most of the me (20)
CYDY CytoDyn Inc
09/28/2020 5:24:45 PM
Information from the CDC, NIH and F (2)
CYDY CytoDyn Inc
09/28/2020 3:36:52 PM
So, approval is about 8 months out (6)
CYDY CytoDyn Inc
09/27/2020 11:48:25 AM
Oncoimmune's drug downregulates NF- (8)
CYDY CytoDyn Inc
09/27/2020 2:23:17 AM
Both have made comments on Twitter (12)
CYDY CytoDyn Inc
09/27/2020 12:00:32 AM
With a 100% infection rate in the U (10)
CYDY CytoDyn Inc
09/26/2020 2:20:54 PM
For an unknown reason, NP felt CYDY (8)
CYDY CytoDyn Inc
09/26/2020 1:27:58 AM
a misstep with the BLA with HIV Whe (5)
CYDY CytoDyn Inc
09/25/2020 6:06:00 PM
Still better than back in 2012 when (5)
CYDY CytoDyn Inc
09/25/2020 6:02:17 PM
"Pay attention to the fundamentals. (2)
CYDY CytoDyn Inc
09/25/2020 5:58:55 PM
Not me, no buyout!!! Now if it's a (1)
CYDY CytoDyn Inc
09/25/2020 5:54:50 PM
I'll get excited when Nader blinks (4)
CYDY CytoDyn Inc
09/25/2020 5:20:42 AM
Quotes are from the linked paper. S (14)
CYDY CytoDyn Inc
09/24/2020 11:16:40 PM
The fact is Incelldx owns all the d (3)
CYDY CytoDyn Inc
09/24/2020 1:00:11 AM
Alzheimer's and Parkinson's is ofte (10)
CYDY CytoDyn Inc
09/23/2020 9:17:53 PM
OHM, how?why? does the parceling of (5)
CYDY CytoDyn Inc
09/23/2020 9:00:00 AM
Dear Diary All the cool kids pick o (24)
CYDY CytoDyn Inc
09/23/2020 1:33:05 AM
Dr. Yo and Dr. Patterson's approach (4)
CYDY CytoDyn Inc
09/23/2020 12:29:35 AM
Nasdaq - Most likely the last piece
CYDY CytoDyn Inc
09/23/2020 12:16:40 AM
NP stated something about paying a (7)
CYDY CytoDyn Inc
09/22/2020 8:41:31 AM
Share price depends on timeline and (4)
CYDY CytoDyn Inc
09/22/2020 3:37:15 AM
If they cover all CCR5 receptors it (10)
CYDY CytoDyn Inc
09/22/2020 2:01:30 AM
If Dr. Jonas Sacha succeeds in usin (7)
CYDY CytoDyn Inc
09/22/2020 1:28:57 AM
It's still being bandied about that (13)
CYDY CytoDyn Inc
09/22/2020 12:15:49 AM
My highest hope is that in cancer l (3)
CYDY CytoDyn Inc
09/21/2020 7:32:36 PM
The terms of the COViD-19 distribut
CYDY CytoDyn Inc
09/21/2020 4:11:32 PM
If your cost average is $1 or less (8)
CYDY CytoDyn Inc
09/21/2020 1:59:50 PM
strength of signal Most likely Nade
Go to page:
  • << First
  • < Previous
  • 96
  • 97
  • Next >

Recent Articles

  • Projected Expansion of Small Molecule CDMO Market by 2034
  • Unleashing Speed: RedwoodX Exchange's Latest Trading Engine
  • Future of Financial Markets in South Africa Amidst Global Factors
  • Trading Changes for HCM III Acquisition Corp. Shares and Warrants
  • Leading Edge Materials Shows Improved Financials and Strategy
  • Highlights from Foresight Technology's Recent AGM Meeting
  • Luraco Technologies Celebrates First Responders with Chair Contest
  • Innovative Designer Brings Life to Unique Plush Rat Toy
  • Simulations Plus, Inc. Securities Class Action Investigation Insights
  • Fluor Corporation Faces Class Action for Alleged Misconduct
  • Comcast Launches New Store for Enhanced Customer Experience
  • Datavault AI's Nathaniel Bradley to Showcase Innovations at XRP Event
  • Innovative Toilet Cleaning Solution Enhances Household Hygiene
  • Morse Micro's Award-Winning SoC Revolutionizes IoT Connectivity
  • Micron Technology Set for Strong Q4 with AI Demand Boost
  • Darden Restaurants Faces Stock Decline Amid Q1 Results
  • Huawei's Groundbreaking AI Security Solution for Modern Campuses
  • Innovative Smartphone Holder Revolutionizes Video Filming
  • Consumer Watchdog Unveils New Video on California’s Energy Legislation
  • Explore 'The Theory of Spice' from The Yogi Foundation
  • California's New Bill 848: A Groundbreaking Step for Student Safety
  • Lennox Approves Substantial Quarterly Dividend for Investors
  • OneDigital Secures Major Investment to Accelerate Growth
  • Innovative Light-Up Play Mat for Children's Entertainment
  • Join the Upcoming Women in CyberSecurity Virtual Career Fair
  • Digital Breast Tomosynthesis Market: Growth and Forecast Insights
  • Preferred Employers Insurance Welcomes Kimberly Wagner to Leadership
  • Projected Growth of the Skincare Packaging Market to $8.05 Billion
  • JWU Introduces Pioneering 3-Year Hospitality Degree Program
  • BreachLock Secures Recognition for Cybersecurity Innovations
  • ISX Financial Enhances Partnership with APOEL FC Through 2027
  • Bitlight Labs Secures $9.6 Million for Bitcoin Payment Innovations
  • WiMi Hologram Cloud Introduces Advanced Quantum Neural Network
  • Discovering the Ingenious PYMSTER MAT for Playtime Fun
  • Big Horn Outdoors® Invites TikTok Creators for Grill Challenge
  • Mesirow Facilitates Strategic Sale of Superior Lithographics
  • NUS Enterprise Unveils New Framework for Innovation and Growth
  • Top ETFs for Q4 Growth: Key Picks and Market Insights
  • OneDigital Secures Major Investment to Fuel Future Growth
  • FedEx's Strong Q1 Results Prompt Analyst Target Adjustments
  • Discover the Charm of Winter Landscapes Through Stamps
  • SlotsUp 2.0: A Complete Overhaul for Enhanced User Experience
  • Exploring the Future of the Robot End-Effector Market Growth
  • Significant Growth Expected in Sleep Aids Market by 2033
  • Le Walk's $4.1M Funding to Transform Travel Experiences
  • Discover Grundfos' Commitment to Sustainable Water Solutions
  • The Race for AI Supremacy: Buck Sexton’s Urgent Warning
  • DeAgentAI Reaches New Heights with $457 Million Valuation
  • Nvidia and Intel's Bold Move Reshapes AI Semiconductor Landscape
  • Innovative Balloon Holder Solution for Safe Transport
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site